Recombinant Human Serpin G1 His-tag Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 10951-PI

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
10951-PI-100
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

CHO

Accession #

P05155.2

Conjugate

Unconjugated

Applications

Enzyme Activity

View all Serpin G1/C1 Inhibitor Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human Serpin G1/C1 Inhibitor protein
Asn23-Ala500 with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Asn23

Predicted Molecular Mass

54 kDa

SDS-PAGE

89-98 kDa, under reducing conditions

Activity

Measured by its ability to inhibit Recombinant Human Complement Component C1s (Catalog # 2060-SE) cleavage of a colorimetric peptide substrate, N-carbobenzyloxy-Lys-ThioBenzyl ester (Z-K-SBzl).
The IC50 is <5 nM, as measured under the described conditions.

Scientific Data Images for Recombinant Human Serpin G1 His-tag Protein, CF

Recombinant Human Serpin G1 His-tag Protein SDS-PAGE.

2 μg/lane of Recombinant Human Serpin G1 His-tag Protein (Catalog # 10951-PI) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 89-98 kDa.

Formulation, Preparation and Storage

10951-PI
Formulation Lyophilized from a 0.2 μm filtered solution in Sodium Acetate and NaCl.
Reconstitution Reconstitute at 0.5 mg/mL in sterile, deionized water.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Serpin G1/C1 Inhibitor

C1-inhibitor (C1-INH), also known as Serpin G1, is a 478 amino acid acute phase plasma glycoprotein member of the serpin superfamily of serine protease inhibitors.  C1 inhibitor, like many other serpin family members, contains a highly conserved C-terminal serpin domain with a reactive center loop that protrudes to present a peptide for proteolytic attack (1). Binding disrupts the protease active site and traps it in a covalent complex with C1-inhibitor resulting in inactivation of the protease. C1 inhibitor also contains a highly glycosylated N- terminus and a unique C-terminal tail that has been suggested to serve as a barrier for transition to an inactive latent form (2). C1 inhibitor is synthesized and secreted primarily by hepatocytes but also by other cells such as monocytes, fibroblasts, and macrophages (1). C1 inhibitor is the sole physiological inhibitor of activated classical complement pathway serine proteases C1r and C1s (3). In addition, C1 inhibitor can inhibit multiple other serine proteases including plasma kallikrein and coagulation factor XIIa from the contact activation system, MASP-1 and MASP-2 proteases from the mannose binding lectin pathway, factor XIa and thrombin from the coagulation system, and plasmin and tissue plasminogen activator from the fibrinolytic system (3). Serpin G1 deficiency, whether caused by deletions, mutations, or inactivation, results in an autosomal dominantly inheritable potentially lethal disease, hereditary angioedema (HAE) (1). Some mutations in the SerpinG1 gene are also associated with age-related macular degeneration (4). Given the role C1-inhibitor plays as a potent anti-inflammatory agent, it has been developed for clinical use to treat HAE (1, 5) and considered for treatment of several other conditions including sepsis, acute myocardial infarction, brain injury, transplantation and COVID19 (6-11).

References

  1. Karnaukhova, E. (2013) J. Hematol. Thromb. Dis. 1:3.
  2. Beinrohr, L. et al. (2007) J. Biol. Chem. 282:21100.
  3. Davis, A.E. III (2010) Thromb. Haemost. 104:886.
  4. Ennis, S. et al. (2008) Lancet 372:1828.
  5. Cicardi, M and A. Zanichelli (2010) Drugs Today. 46:867.
  6. Caliezi, C. et al. (2000) Pharmacol. Rev. 52:91.
  7. Thielmann, M. et al. (2006) Eur. J. Cardiothorac. Surg. 30:285.
  8. Singer, M. and Jones, A.M. (2011) Crit. Care 15:203.
  9. Berger, M. et al. (2016) Transplantation 100:1415.
  10. Weiss, E. et al. (2020) Clin. Exp. Emerg. Med. 7:87.
  11. Adesanya, T.M.A. et al. (2021) J. Clin. Immunol. 41:729.

Alternate Names

C1 Inhibitor

Entrez Gene IDs

710 (Human)

Gene Symbol

SERPING1

UniProt

P05155.2

Additional Serpin G1/C1 Inhibitor Products

Product Documents for Recombinant Human Serpin G1 His-tag Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Serpin G1 His-tag Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.